In an article written by Capital Blue Cross, Dr. Michael Colli, a pediatrician from Keystone Health in Chambersburg, PA, noted that as measles cases rise, discussions about childhood vaccines have become more straightforward. The increasing number of cases has heightened parental concern, making preventative discussions more impactful.
Once eradicated in North America, measles has re-emerged significantly, with notable outbreaks in Texas and New Jersey in early 2025. The disease is particularly dangerous for children, with measles cases in 2024 being five times higher than in 2023 (288 compared to 58), primarily affecting individuals 19 years and younger. As of March 1, 2025, West Texas alone reported 146 cases.
Dr. Jeremy Wigginton, Chief Medical Officer at Capital Blue Cross, emphasized the severity of measles, which can lead to permanent hearing loss from ear infections, pneumonia, and encephalitis (brain swelling). An outbreak in February 2025 resulted in one child’s death and several severe respiratory complications.
Measles is extremely contagious, requiring approximately 95% of the population to be vaccinated to achieve herd immunity. The disease spread is facilitated by low vaccination rates and the mobility of unvaccinated international travelers. CDC data reveal that 89% of measles cases in 2024 occurred in unvaccinated individuals.
Regarding vaccination records, Dr. Wigginton advises individuals unsure of their vaccination status to consult family members or primary care physicians. State health departments and vaccine registries can also provide this information, and a blood test can determine the presence of antibodies against measles.
Capital Blue Cross ensures that the MMR vaccine is covered under most of its health plans as a preventive measure, aligning with CDC guidelines. This initiative underscores the importance of vaccinations in protecting communities against highly contagious and potentially fatal diseases.
